Related Experiment Video
Updated: Jun 18, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association
Julia S Kenkre1,2, Tina Mazaheri1,2, R Dermot G Neely3,4
1Department of Clinical Biochemistry, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
Insights
New UK guidelines offer evidence-based lipid testing recommendations for laboratories and clinicians to assess cardiovascular risk. This aims to improve management of atherosclerotic cardiovascular disease, a leading cause of premature death.
Area of Science:
- Cardiovascular Medicine
- Clinical Biochemistry
- Public Health
Background:
- Atherosclerotic cardiovascular disease is a leading cause of premature mortality in the UK.
- Lipid testing is crucial for cardiovascular risk assessment and clinical decision-making.
- Existing national guidelines for lipid testing and reporting in the UK are lacking.
Purpose of the Study:
- To establish consensus-based, evidence-driven guidelines for lipid testing and reporting in the UK.
- To provide recommendations for standard and enhanced lipid profiles.
- To guide laboratories and clinicians in interpreting and reporting lipid test results.
Main Methods:
- A multidisciplinary group of UK experts reviewed published evidence.
- Consensus was reached on key aspects of lipid testing and reporting.
- Guidance was developed for standard and enhanced lipid profiles, including specific analytes and calculations.
Main Results:
- Recommendations cover the composition of standard and enhanced lipid profiles.
- Specific guidance is provided for including apolipoprotein B and lipoprotein (a).
- The Sampson-NIH calculation for LDL-c estimation and criteria for flagging abnormal results are recommended.
Conclusions:
- The consensus guidance provides a framework for consistent lipid testing and reporting across the UK.
- Implementation of these guidelines can enhance cardiovascular risk assessment and patient management.
- The guidance is endorsed by HEART UK and The Association for Laboratory Medicine.
Abstract:
Atherosclerotic cardiovascular disease remains a major cause of premature death in the United Kingdom. Lipid testing is a key tool used to assess cardiovascular risk and guide clinical management decisions. There are currently no national guidelines to provide evidence-based recommendations on lipid testing and reporting for UK laboratories and clinicians. Here we present consensus guidance, following a review of published evidence by a multidisciplinary group of UK experts across a range of laboratory and clinical services. Recommendations include the composition of a standard lipid profile; indications for, and composition of, an enhanced lipid profile including apolipoprotein B and lipoprotein (a); use of the Sampson-NIH calculation for LDL-c estimation and guidance on when to flag abnormal results. This consensus guidance on lipid testing and reporting in the United Kingdom has been endorsed by HEART UK and The Association for Laboratory Medicine.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

